1-7 of 7
Samuel Granjeaud
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer

Open Access
Stéphane Fattori, Aude Le Roy, Jemila Houacine, Lucie Robert, Riad Abes, Laurent Gorvel, Samuel Granjeaud, Marie-Sarah Rouvière, Amira Ben Amara, Nicolas Boucherit, Carole Tarpin, Jihane Pakradouni, Emmanuelle Charafe-Jauffret, Gilles Houvenaeghel, Eric Lambaudie, François Bertucci, Philippe Rochigneux, Anthony Gonçalves, Arnaud Foussat, Anne-Sophie Chrétien, Daniel Olive
Journal: Cancer Research
Cancer Res (2023) 83 (18): 3026–3044.
https://doi.org/10.1158/0008-5472.CAN-23-0613
Published: 15 September 2023
View articletitled, CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Open the PDF for CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 3239: Selective depletion of regulatory T cells by ALD2510, a novel IL-2-sparing anti-CD25 antibody, synergizes with PD-1 blockade in breast and gynecologic cancers

Free
Stéphane FATTORI, Aude Le Roy, Jemila Houacine, Lucie Robert, Riad Abes, Laurent Gorvel, Samuel Granjeaud, Marie-Sarah Rouvière, Amira Ben Amara, Nicolas Boucherit, Carole Tarpin, Jihane Pakradouni, Emmanuelle Charafe-Jauffret, Julien Barrou, Gilles Houvenaeghel, Eric Lambaudie, François Bertucci, Philippe Rochigneux, Anthony Gonçalves, Arnaud Foussat, Anne-Sophie Chrétien, Daniel Olive
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3239.
https://doi.org/10.1158/1538-7445.AM2023-3239
Published: 04 April 2023
View articletitled, Abstract 3239: Selective depletion of regulatory T cells by ALD2510, a novel IL-2-sparing anti-CD25 antibody, synergizes with PD-1 blockade in breast and gynecologic cancers
Journal Articles

LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker

Free
Christian Bressy, Sophie Lac, Jérémy Nigri, Julie Leca, Julie Roques, Marie-Nöelle Lavaut, Véronique Secq, Fabienne Guillaumond, Thi-Thien Bui, Daniel Pietrasz, Samuel Granjeaud, Jean-Baptiste Bachet, Mehdi Ouaissi, Juan Iovanna, Sophie Vasseur, Richard Tomasini
Journal: Cancer Research
Series: Author Choice
Cancer Res (2018) 78 (4): 909–921.
https://doi.org/10.1158/0008-5472.CAN-15-2790
Published: 14 February 2018
View articletitled, LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
Open the PDF for LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker in another window
Includes: Supplementary data
Journal Articles

JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia

Free
Maria De Grandis, Florence Bardin, Cyril Fauriat, Christophe Zemmour, Abdessamad El-Kaoutari, Arnauld Sergé, Samuel Granjeaud, Laurent Pouyet, Camille Montersino, Anne-Sophie Chretien, Marie-Joelle Mozziconacci, Remy Castellano, Ghislain Bidaut, Jean-Marie Boher, Yves Collette, Stéphane J.C. Mancini, Norbert Vey, Michel Aurrand-Lions
Journal: Cancer Research
Cancer Res (2017) 77 (23): 6627–6640.
https://doi.org/10.1158/0008-5472.CAN-17-1223
Published: 30 November 2017
View articletitled, JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia
Open the PDF for JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Abstract A61: CAF-derived ANXA6+-exosomes support pancreatic cancer aggressiveness and serve as a circulating biomarker

Free
Julie Leca, Sebastien Martinez, Sophie Lac, Jeremy Nigri, Veronique Secq, Marion Rubis, Nelson Dusetti, Celine Loncle, Julie Roques, Daniel Pietrasz, Stéphane Garcia, Samuel Granjeaud, Mehdi Ouaissi, Jean-Baptiste Bachet, Christine Brun, Juan L. Iovanna, Pascale Zimmermann, Sophie Vasseur, Richard Tomasini
Journal: Cancer Research
Cancer Res (2016) 76 (24_Supplement): A61.
https://doi.org/10.1158/1538-7445.PANCA16-A61
Published: 14 December 2016
View articletitled, Abstract A61: CAF-derived ANXA6+-exosomes support pancreatic cancer aggressiveness and serve as a circulating biomarker
Journal Articles

Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy

Free
Kieu-Suong Le, Marie-Laure Thibult, Sylvain Just-Landi, Sonia Pastor, Françoise Gondois-Rey, Samuel Granjeaud, Florence Broussais, Reda Bouabdallah, Renaud Colisson, Christophe Caux, Christine Ménétrier-Caux, Dominique Leroux, Luc Xerri, Daniel Olive
Journal: Cancer Research
Cancer Res (2016) 76 (16): 4648–4660.
https://doi.org/10.1158/0008-5472.CAN-15-0589
Published: 14 August 2016
View articletitled, Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy
Open the PDF for Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy in another window
Includes: Supplementary data
Journal Articles

Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

Free
Christine Pasero, Gwenaëlle Gravis, Mathilde Guerin, Samuel Granjeaud, Jeanne Thomassin-Piana, Palma Rocchi, Maria Paciencia-Gros, Flora Poizat, Mélanie Bentobji, Francine Azario-Cheillan, Jochen Walz, Naji Salem, Serge Brunelle, Alessandro Moretta, Daniel Olive
Journal: Cancer Research
Cancer Res (2016) 76 (8): 2153–2165.
https://doi.org/10.1158/0008-5472.CAN-15-1965
Published: 14 April 2016
View articletitled, Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity
Open the PDF for Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity in another window
Includes: Supplementary data